LC-MS法测定人血浆匹伐他汀药物浓度及应用

陈尧 谭志荣 周淦 欧阳冬生 张坚 周宏灏

中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 134-137.

PDF(721 KB)
PDF(721 KB)
中国药学杂志 ›› 2011, Vol. 46 ›› Issue (2) : 134-137.
论著

LC-MS法测定人血浆匹伐他汀药物浓度及应用

  • 陈尧,谭志荣,周淦,欧阳冬生,张坚,周宏灏*
作者信息 +

LC-MS Determination of Pitavastatin in Human Plasma and Its Application

  • CHEN Yao, TAN Zhi-rong, ZHOU Gan, OU-YANG Dong-sheng, ZHANG Jian, ZHOU Hong-hao*
Author information +
文章历史 +

摘要

目的 建立液质联用(LC-MS直接沉淀法测定人血浆匹伐他汀的浓度。方法 Waters Cosmosil Packed Coulmn C18-MS-Ⅱ(2.0 mm×150 mm, 5 μm色谱柱, 流动相为10 mmol·L-1甲酸胺(含0.1%甲酸-乙腈(40∶60, 流速为0.3 mL·min-1, 进样体积为20 μL, 柱温为40 ℃, 样品室温度为15 ℃,采用内标定量法,内标为罗素伐他汀。结果 匹伐他汀线性范围为0.5~1 000 ng·mL-1, 最低检测限为0.1 ng·mL-1, 方法灵敏、稳定、特异性高, 并已成功地应用到人血浆匹伐他汀药动学研究。 结论 该方法简便、准确、重复性好, 可以准确地定量人血浆匹伐他汀的浓度, 适于药理科研。

Abstract

OBJECTIVE To develop a LC-MS method with direct precipitation of sample protein to determinate the concentration of pitavastatin in human plasma. METHODS LC-MS equipment with ESI source and Waters Cosmosil Packed Coulmn C18-MS-Ⅱ(2.0 mm×150 mm, 5 μm were used in the experiment. The column temperature was set at 40 ℃. 10 mmol·L-1 ammonium formate (contain 0.1% formic acid-acetonitrile(40∶60 was used as mobile phase and the flow rate was 0.3 mL·min-1. The sample room temperature was set at 15 ℃ and the injection volume was 20 μL. Rosuvastatin was taken as the internal standard. RESULTS Pitavastatin was linear in the range of 0.5-1 000 ng·mL-1. The limitation of detection for pitavastatin was 0.1 ng·mL-1. The method was sensitivity, stability and specificity and was used for pharmacokinetic study of pitavastatin in human successfully. CONCLUSION The method is simple, accurate, reproducibility for the determination of pitavastatin in human plasma and suitable for the study in pharmacology.

关键词

匹伐他汀 / 液质联用 / 直接沉淀

Key words

pitavastatin / LC-MS / precipitation

引用本文

导出引用
陈尧 谭志荣 周淦 欧阳冬生 张坚 周宏灏. LC-MS法测定人血浆匹伐他汀药物浓度及应用[J]. 中国药学杂志, 2011, 46(2): 134-137
CHEN Yo;TN Zhi-rong;ZHOU Gn;OU-YNG Dong-sheng;ZHNG Jin;ZHOU Hong-ho. LC-MS Determination of Pitavastatin in Human Plasma and Its Application[J]. Chinese Pharmaceutical Journal, 2011, 46(2): 134-137

参考文献


[1] GUO D L,ZHANG G X,SUN H Y. Super-statin family, a new member-Pitavastatin[J]. Qilu Pharm Affairs(齐鲁药事, 2004, 23(1:61-62.
[2] HE X R, ZOU D, JIANG W Q, et al. A new lipid-lowering agent agent: pitavastatin[J]. Chin J New Drug(中国新药杂志, 2005,14(4:483-487.
[3] WEN J H, XIONG Y Q. Pharmacokinetic characteristics of pitavastatin[J]. Chin J Clin Pharmacol(中国临床药理学杂志, 2008, 24 (4:364-367.
[4] TANG B, YANG G P, YUAN H, et al. Clinical research of pitavastatin on lipid-lowering[J]. Cent South Pharm(中南药学, 2008, 6(2:226-229.
[5] WANG L L, CHEN X Y, SONG B, et al. Determination of pitavastatin in human plasma by liquid chromatography tandem mass spectrometry[J]. Chin J New Drugs Clin Rein(中国新药与临床杂志, 2007,26(11:805-808.
[6] OJHA A, GUTTIKAR S, VAYEDA C, et al. Determination of pitavastatin from human plasma using high performance liquid chromatography with fluorescence detection[J]. Chin J Chromatogr(色谱, 2007, 25(5:715-718.
[7] KOJIMA J, FUJINO H, YOSIMURA M, et al. Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection[J]. J Chromatogr B Biomed Sci Appl, 1999,724(1:173-180.
PDF(721 KB)

106

Accesses

0

Citation

Detail

段落导航
相关文章

/